Efficacy and Safety of SR1375 in Adult Patients With CAP

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Community-acquired Pneumonia

In brief

This is a phase 2 study to evaluate the efficacy and safety of SR1375 in hospitalized adult patients with CAP. Patients will receive SR1375 or placebo for 8 weeks. The study duration for each patient is up to 10 weeks.

Key facts

Study ID

NCT06577558

Run by

Shanghai SIMR Biotechnology Co., Ltd.

People needed

240

Starts

2024-09-10

Expected to finish

2025-10-30

Last updated by the study team

2025-07-09

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Lishui Central Hospital — Lishui, Zhejiang, China (enrolling)
• Peking University Third Hospital — Beijing, Beijing Municipality, China (enrolling)
• Zhangzhou Hospital — Zhangzhou, Fujian, China (enrolling)
• Gaozhou People's Hospital — Gaozhou, Guangdong, China (enrolling)
• The First Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China (enrolling)
• The Third Affiliated Hospital of Southern Medical University — Guangzhou, Guangdong, China (enrolling)
• Nanfang Hospital — Guangzhou, Guangdong, China (enrolling)
• The First Affiliated Hospital of Shantou University Medical College — Shantou, Guangdong, China (enrolling)
• Yulin First People's Hospital — Yulin, Guangxi, China (enrolling)
• The First Hospital of Hebei Medical University — Shijiazhuang, Hebei, China (enrolling)
• Daqing Longnan Hospital — Daqing, Heilongjiang, China (enrolling)
• Daqing People's Hospital — Daqing, Heilongjiang, China (enrolling)
• Shangqiu People's Hospital — Shangqiu, Henan, China (enrolling)
• Henan Provincial People's Hospital — Zhengzhou, Henan, China (enrolling)
• Yueyang Central Hospital — Yueyang, Hunan, China (enrolling)
• The First Affiliated Hospital of Chengdu Medical College — Chengdu, Sichuan, China (enrolling)
• Fuyang People's Hospital — Fuyang, Anhui, China (enrolling)
• Jiangxi Provincial People's Hospital — Nanchang, Jiangxi, China (enrolling)
• The First Affiliated Hospital of Nanchang University — Nanchang, Jiangxi, China (enrolling)
• Dalian Central Hospital — Dalian, Liaoning, China (enrolling)
• The Second Hospital of Dalian Medical University — Dalian, Liaoning, China (enrolling)
• Weifang Second People's Hospital — Weifang, Shandong, China (enrolling)
• Zibo Municipal Hospital — Zibo, Shandong, China (enrolling)
• Zhongshan Hospital — Shanghai, Shanghai Municipality, China (enrolling)
• Shanghai Tongren Hospital — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.